                         SEQUENCE LISTING

<110>  Novartis AG
       Cao, Alexander
       Morrissey, Michael
       Sonkin, Dmitriy
       Palmer, Michael
 
<120>  Treatment of cancer

<130>  PAT055204-TW-NP

<150>  61/676484
<151>  2012-07-27

<150>  61/769271
<151>  2013-02-26

<150>  61/829327
<151>  2013-05-31

<160>  6     

<170>  PatentIn version 3.5

<210>  1
<211>  23
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Oligonucleotide

<400>  1
ctgtgcatag ccaagacctt ctc                                               23


<210>  2
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Oligonucleotide

<400>  2
cgtaatggaa ccccaatacc a                                                 21


<210>  3
<211>  14
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Oligonucleotide

<400>  3
cttcgggaat ctgg                                                         14


<210>  4
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Oligonucleotide

<400>  4
tgctcaagga caccgtctac ac                                                22


<210>  5
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Oligonucleotide

<400>  5
ggatccactc tggagggcta t                                                 21


<210>  6
<211>  17
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Oligonucleotide

<400>  6
cttcgatggg acccgag                                                      17


